International law firm DAC Beachcroft has advised Icon Oncology Group on its acquisition of Leeds-based cancer and haematology provider Nova Healthcare.
The deal marks the latest step in the Australian cancer care provider's expansion in the UK, adding Nova Healthcare’s existing services and established consultant relationships in Yorkshire to its growing cancer care presence.
Nova Healthcare is based within Leeds Cancer Centre at St James’s University Hospital, where it provides oncology and haematology services, including highly specialised Gamma Knife treatment for NHS and privately funded patients.
The acquisition follows the Group’s plans to develop a new Icon Cancer Centre at AMT Headingley Stadium in Leeds, which will provide advanced radiotherapy and oncology imaging.
Together, the two developments have the potential to increase access to specialist cancer care for patients across Yorkshire and the North of England.
James Reed, Corporate Partner, said: “Icon Oncology Group has ambitious plans for cancer care in the UK, and the acquisition of Nova Healthcare represents another important step in that growth. Combining the Group's plans for further capacity in Leeds with Nova’s established services has the potential to continue increasing access to specialist treatment for patients across the region.
“Completing our first corporate M&A transaction together marks a significant milestone in our relationship and we look forward to supporting Icon Oncology Group as its UK presence continues to grow.”
